Back
13
Also listed as
APNHF
OTC
Day Range
$7.48
$7.64
52-Week Range
$5.24
$9.92
Volume
13
50D / 200D Avg
$7.60
/
$6.43
Prev Close
$7.50
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.1 | 0.3 |
| P/B | 0.0 | 3.0 |
| ROE % | -1.3 | 3.7 |
| Net Margin % | -2.5 | 3.8 |
| Rev Growth 5Y % | 3.5 | 10.0 |
| D/E | 0.4 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$14.54
$12.53 – $16.95
|
44.00B | 1 |
| FY2027 |
$13.46
$11.60 – $15.69
|
41.39B | 1 |
| FY2026 |
$11.84
$10.20 – $13.80
|
44.14B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-03 | N/A | $0.19 | — |
| 2025-09-01 | N/A | -$0.44 | — |
| 2025-03-03 | N/A | $0.28 | — |
| 2024-09-03 | $0.57 | $0.26 | -54.4% |
| 2024-03-14 | N/A | $0.28 | — |
| 2023-06-30 | $0.48 | $0.31 | -35.7% |
| 2022-12-31 | N/A | $0.36 | — |
| 2022-06-30 | $0.48 | $0.42 | -11.0% |
Dividend History
Yield
0.03%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Oct 03, 2025 | Oct 21, 2025 | $0.12 | 2.17% |
| Sep 20, 2024 | Oct 08, 2024 | $0.20 | 1.90% |
| Sep 21, 2023 | Oct 11, 2023 | $0.18 | 2.10% |
| Sep 22, 2022 | Oct 11, 2022 | $0.18 | 2.31% |
| Sep 22, 2021 | Oct 12, 2021 | $0.18 | 1.18% |
| Oct 04, 2018 | Oct 23, 2018 | $0.21 | 1.33% |
| Oct 05, 2017 | Oct 24, 2017 | $0.21 | 0.65% |
| Oct 05, 2016 | Oct 25, 2016 | $0.18 | 0.79% |
| Oct 07, 2015 | Oct 27, 2015 | $0.16 | 0.72% |
| Oct 08, 2014 | Oct 28, 2014 | $0.17 | 0.56% |
| Oct 09, 2013 | Oct 29, 2013 | $0.16 | 0.58% |
| Oct 10, 2012 | Oct 30, 2012 | $0.19 | 1.27% |
| Oct 12, 2011 | Nov 01, 2011 | $0.65 | 0.24% |
| Oct 06, 2010 | Oct 21, 2010 | $0.50 | 0.20% |
Key Takeaways
Revenue grew 3.52% annually over 5 years — modest growth
Earnings declined -124.59% over the past year
Debt/Equity of 0.43 — conservative balance sheet
Generating 104.00M in free cash flow
PEG of 0.40 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.52%
Growth
Revenue Growth (5Y)
3.52%
Revenue (1Y)-3.00%
Earnings (1Y)-124.59%
FCF Growth (3Y)-78.91%
Quality
Return on Equity
-1.28%
ROIC0.89%
Net Margin-2.50%
Op. Margin3.31%
Safety
Debt / Equity
0.43
Current Ratio2.21
Interest Coverage0.87
Valuation
P/E Ratio
-3.07
Forward P/EN/A
P/B Ratio0.04
EV/EBITDA22.99
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3.00% | Revenue Growth (3Y) | 3.21% |
| Earnings Growth (1Y) | -124.59% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3.52% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 43.36B | Net Income (TTM) | -1.08B |
| ROE | -1.28% | ROA | -0.80% |
| Gross Margin | 44.11% | Operating Margin | 3.31% |
| Net Margin | -2.50% | Free Cash Flow (TTM) | 104.00M |
| ROIC | 0.89% | FCF Growth (3Y) | -78.91% |
| Safety | |||
| Debt / Equity | 0.43 | Current Ratio | 2.21 |
| Interest Coverage | 0.87 | ||
| Dividends | |||
| Dividend Yield | 0.03% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3.07 | Forward P/E | N/A |
| P/B Ratio | 0.04 | P/S Ratio | 0.08 |
| PEG Ratio | 0.40 | Forward PEG | N/A |
| EV/EBITDA | 22.99 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 3.13% | ||
| Market Cap | 3.32B | Enterprise Value | 33.03B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 43.36B | 44.71B | 40.71B | 38.61B | 37.77B |
| Net Income | -1.08B | 4.40B | 5.23B | 6.49B | 4.81B |
| EPS (Diluted) | -2.44 | 9.91 | 11.77 | 14.32 | 10.53 |
| Gross Profit | 19.13B | 19.42B | 18.41B | 18.31B | 17.79B |
| Operating Income | 1.44B | 7.00B | 7.82B | 8.67B | 7.07B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 135.89B | 139.16B | 134.28B | 111.38B | 109.68B |
| Total Liabilities | 51.00B | 54.29B | 48.05B | 40.43B | 44.06B |
| Shareholders' Equity | 84.89B | 84.86B | 86.24B | 70.94B | 65.63B |
| Total Debt | 36.12B | 36.46B | 29.28B | 22.25B | 24.87B |
| Cash & Equivalents | 6.41B | 12.34B | 10.91B | 6.18B | 8.55B |
| Current Assets | 38.70B | 44.09B | 44.50B | 34.56B | 32.71B |
| Current Liabilities | 17.50B | 24.38B | 23.15B | 23.40B | 36.75B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#780 of 825
Recent Activity
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026